Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerardo Russomanno

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Case Reports|March 12, 2026
Effects of Immersive Natural Sound Stimulation With the Spherison Device on Anxiety Symptoms: A Case SeriesDonatella Marazziti, Gerardo Russomanno, Matteo Gambini, et al.
Expert Opinion on Investigational Drugs|July 21, 2025
Promising experimental drugs for obsessive-compulsive personality disorderDonatella Marazziti, Riccardo Gurrieri, Matteo Gambini, et al.
Life (Basel, Switzerland)|March 27, 2025
Third-Generation Antipsychotics: The Quest for the Key to NeurotrophismFederico Mucci, Alessandro Arone, Riccardo Gurrieri, et al.
Brain Sciences|June 26, 2026
From Resistance to Redesign-The Emerging Logic of Hybrid Care in Treatment-Resistant DepressionFederico Mucci, Riccardo Gurrieri, Siham Bouanani, et al.
Expert Opinion on Pharmacotherapy|November 17, 2025
Innovative treatment approaches for paediatric obsessive-compulsive disorderDonatella Marazziti, Riccardo Gurrieri, Matteo Gambini, et al.
Brain Sciences|February 27, 2026
Sensory Deprivation and the Brain: Neurobiological Mechanisms, Psychological Effects, and Clinical ImplicationsDonatella Marazziti, Gerardo Russomanno, Matteo Gambini, et al.
Brain Sciences|September 27, 2025
Botulinum Toxin: An Unconventional Tool for the Treatment of Depression?Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2025
Psychotropic drugs in pregnancy and lactationDonatella Marazziti, Lara Foresi Crawther, Alessandro Arone, et al.
Expert Review of Neurotherapeutics|December 19, 2024
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspectiveDonatella Marazziti, Francesco Weiss, Riccardo Gurrieri, et al.
Expert Opinion on Pharmacotherapy|April 7, 2026
Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerationsDonatella Marazziti, Matteo Gambini, Riccardo Gurrieri, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Case Reports|March 12, 2026
Effects of Immersive Natural Sound Stimulation With the Spherison Device on Anxiety Symptoms: A Case SeriesDonatella Marazziti, Gerardo Russomanno, Matteo Gambini, et al.
Expert Opinion on Investigational Drugs|July 21, 2025
Promising experimental drugs for obsessive-compulsive personality disorderDonatella Marazziti, Riccardo Gurrieri, Matteo Gambini, et al.
Life (Basel, Switzerland)|March 27, 2025
Third-Generation Antipsychotics: The Quest for the Key to NeurotrophismFederico Mucci, Alessandro Arone, Riccardo Gurrieri, et al.
Brain Sciences|June 26, 2026
From Resistance to Redesign-The Emerging Logic of Hybrid Care in Treatment-Resistant DepressionFederico Mucci, Riccardo Gurrieri, Siham Bouanani, et al.
Expert Opinion on Pharmacotherapy|November 17, 2025
Innovative treatment approaches for paediatric obsessive-compulsive disorderDonatella Marazziti, Riccardo Gurrieri, Matteo Gambini, et al.
Brain Sciences|February 27, 2026
Sensory Deprivation and the Brain: Neurobiological Mechanisms, Psychological Effects, and Clinical ImplicationsDonatella Marazziti, Gerardo Russomanno, Matteo Gambini, et al.
Brain Sciences|September 27, 2025
Botulinum Toxin: An Unconventional Tool for the Treatment of Depression?Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2025
Psychotropic drugs in pregnancy and lactationDonatella Marazziti, Lara Foresi Crawther, Alessandro Arone, et al.
Expert Review of Neurotherapeutics|December 19, 2024
Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspectiveDonatella Marazziti, Francesco Weiss, Riccardo Gurrieri, et al.
Expert Opinion on Pharmacotherapy|April 7, 2026
Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerationsDonatella Marazziti, Matteo Gambini, Riccardo Gurrieri, et al.
Pageof 2